MDGL insider sale notice: 360 shares tied to RSU vesting

Madrigal Pharmaceuticals related party reported proposed sales of common stock under a Form 144 notice.

Rhea-AI Filing Summary

Madrigal Pharmaceuticals related party reported proposed sales of common stock under a Form 144 notice. The filing lists a proposed sale of 360 shares tied to a Restricted Stock Unit vesting on 03/06/2026, and discloses prior dispositions of 429 and 263 shares on 01/20/2026 by Shannon Kelley. The broker listed is Morgan Stanley Smith Barney LLC.

Insights

Securities Compliance Counsel

Routine Form 144 notice of proposed resale activity by an insider; no new material corporate event.

The filing lists a proposed sale of 360 common shares associated with a Restricted Stock Unit vesting on 03/06/2026 and two prior dispositions of 429 and 263 shares on 01/20/2026.

Timing and method of sale are typical provided the notice meets Rule 144 conditions; subsequent Form 4 or broker reports would show execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MDGL's Form 144 filing mean for shareholders?

It notifies the market of an insider's intent to sell shares, providing transparency about potential share supply. The filing shows a proposed sale of 360 shares on 03/06/2026 and prior dispositions of 429 and 263 shares on 01/20/2026.

Who is listed as the selling party in the MDGL Form 144?

The filing identifies Shannon Kelley as the reporting party associated with the transactions. The record shows prior dispositions by Shannon Kelley on 01/20/2026 of 429 and 263 shares.

How many shares are tied to the RSU vesting in this Form 144 for MDGL?

The Form 144 shows 360 common shares tied to a Restricted Stock Unit grant that vested on 03/06/2026. The entry labels the event as "Vesting of Restricted Stock Units."

Which broker-dealer is listed for the proposed MDGL sale?

The filing lists Morgan Stanley Smith Barney LLC as the broker-dealer handling the proposed transaction. The address shown is 1 New York Plaza, 8th Floor, New York, NY as provided in the notice.

Does this Form 144 confirm that the shares were sold?

No; Form 144 is a notice of proposed sale rather than a confirmation of execution. The notice lists the proposed 360 share sale on 03/06/2026; execution would appear in later transaction reports.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 06:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034056
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Madrigal Pharmaceuticals, Inc.
SEC File Number	001-33277
Address of Issuer	Four Towers Bridge 200 Barr Harbor Drive, Suite 200 West Conshohocken PENNSYLVANIA 19428
Phone	267-824-2827
Name of Person for Whose Account the Securities are To Be Sold	Shannon Kelley
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	360	158162.4	22939969	03/06/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/05/2026	Restricted Stock Unit Grant	Issuer			360	03/06/2026	Vesting of Restricted Stock Units

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shannon Kelley c/o Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Common Stock	01/20/2026	429	215100.6
Shannon Kelley c/o Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Common Stock	01/20/2026	263	129072.51

144: Remarks and Signature

Remarks	The sale of shares of common stock reported on this Form 144 represents the sale of shares pursuant to a sell-to-cover transaction in order to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units previously granted to the Reporting Person.
Date of Notice	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Shannon Kelley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)